Skip to content
Politically.com Search all
Menu

Kentucky 2026RS

HB 263

AN ACT relating to undesignated glucagon.

Source: Open States / PluralUpdated 2026-11-11 12:11:04 UTC.

Official record

Measure details

Jurisdiction
Kentucky
Session
2026RS
Chamber
lower
Classification
bill
Subjects
Administrative Regulations And Proceedings, Children And Minors, Civil Actions, Diseases, Drugs And Medicines, Education, Elementary And Secondary, Health Care Professionals, Nurses, Pharmacists, Physicians, State Agencies, Teachers
Introduced / first action
2026-01-08 05:00:00

Source-supplied abstracts

Create new sections of KRS Chapter 217 to define terms; permit health care practitioners to prescribe and dispense undesignated glucagon in the name of a school; permit authorized entities to receive, possess, and administer undesignated glucagon to a student during diabetic medical emergencies; permit schools to stock undesignated glucagon; provide for immunity from civil liability for any personal injury resulting from good-faith actions to use undesignated glucagon to treat diabetic medical emergencies; require the Cabinet for Health and Family Services to consult the American Diabetes Association when promulgating administrative regulations related to the administration of undesignated glucagon in schools.

Sponsors

Source-supplied history

Actions

  1. to Health Services (H)

    referral-committee
  2. to Committee on Committees (H)

    referral-committee
  3. introduced in House

    introduction

Recorded votes

Roll calls

No recorded vote is supplied for this bill.

When supplied by the API

Related measures

No resolvable related measure is supplied.